Rapid and Sensitive LC−MS–MS Method for the Determination of Sarpogrelate in Human Plasma
- 132 Downloads
- 5 Citations
Abstract
A rapid and sensitive liquid chromatographic–tandem mass spectrometric method has been developed and validated for the estimation of sarpogrelate in human plasma. Sarpogrelate was extracted from human plasma by solid-phase extraction. Temocapril was used as the internal standard. Heated electron spray ionization mass spectrometry was performed on a TSQ Quantum Ultra MS system. The LC column was a Hypurity C18 and the mobile phase was 2 mM ammonium formate (pH 3.00 ± 0.05):acetonitrile (30:70 v/v). A flow rate of 0.250 mL min−1 was used. The quantitative analyses were carried out in the positive ion and full scan mode over the mass range m/z 60–500. The capillary, vaporiser temperatures were 325 and 200 °C respectively. The sheath gas pressure, spray voltage, collision energy and tube lense were 40, 3,500 V, 19 V, 198 V, respectively, and the mass spectra of the drugs were recorded by total ion monitoring. Retention times and characteristic mass fragments were recorded and the chosen diagnostic mass fragments were monitored in the mass chromatography mode. Signal intensities of each of the mass fragments: m/z 477 [M + H]+ for temocapril, m/z 430 [M + H]+ for sarpogrelate, were used for quantification. The calibration curves (the ratio between the peak areas as signal intensities of the drug analyzed and that of the internal standard (temocapril: m/z 477 [M + H]+) vs. the concentration of drug) exhibited linearity over the concentration range 5.00–2,500.00 ng mL−1 human plasma. The recovery and the accuracy were calculated by comparing the peak areas as the signal intensities of each mass fragment for the drug in spiked samples after solid-phase extraction from human plasma to the peak area as the signal intensity of the mass fragment of internal standard sample. The method involves a rapid solid phase extraction from plasma, simple isocratic chromatography conditions and mass spectrometric detection that enables detection up to picogram levels with a total run time of 3.0 min only. The method was validated over the range of 5.0–2,500.0 ng mL−1. The absolute recoveries for sarpogrelate (93.72%) and IS (91.42%) achieved from spiked plasma samples were consistent and reproducible.
Keywords
Column liquid chromatography Tandem mass spectrometry Selective reaction monitoring Sarpogrelate and temocaprilNotes
Acknowledgments
The authors are indebted to the Directors of Accutest Research Lab for their continuous support and encouragement and for providing necessary facilities to carry out this work.
References
- 1.Kamatsu T, Kitazawa K, Izawa O, Inoue S, Ohshima M, Iida S (1992) Yakubatsu Dotai 6:353–375Google Scholar
- 2.Pertz H, Elz S (1995) J Pharm Pharmacol 47:310–316Google Scholar
- 3.Elz S (1991) Arch Pharmacol 343:R100Google Scholar
- 4.Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996) Neuropsychopharmacology 15:116–124. doi: 10.1016/0893-133X(95)00160-F CrossRefGoogle Scholar
- 5.Doggrell Biomedical Communications, 47 Caronia Crescent, Lynfield, Auckland, New ZealandGoogle Scholar
- 6.Guidance for industry: bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM). May, 2001Google Scholar